A POTENT, ORALLY-ACTIVE, BALANCED AFFINITY ANGIOTENSIN-II AT(1) ANTAGONIST AND AT(2) BINDING INHIBITOR

被引：123

作者：

DELASZLO, SE ^{[1
]}

QUAGLIATO, CS ^{[1
]}

GREENLEE, WJ ^{[1
]}

PATCHETT, AA ^{[1
]}

CHANG, RSL ^{[1
]}

LOTTI, VJ ^{[1
]}

CHEN, TB ^{[1
]}

SCHECK, SA ^{[1
]}

FAUST, KA ^{[1
]}

KIVLIGHN, SS ^{[1
]}

SCHORN, TS ^{[1
]}

ZINGARO, GJ ^{[1
]}

SIEGL, PKS ^{[1
]}

机构：

[1] MERCK RES LABS,DEPT PHARMACOL,W POINT,PA 19486

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1993年 / 36卷 / 21期

关键词：

D O I：

10.1021/jm00073a024

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：3207 / 3210

页数：4

共 50 条

[41] PHARMACOLOGICAL CHARACTERIZATION OF BOSENTAN, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST [J].

CLOZEL, M ;

BREU, V ;

GRAY, GA ;

KALINA, B ;

LOFFLER, BM ;

BURRI, K ;

CASSAL, JM ;

HIRTH, G ;

MULLER, M ;

NEIDHART, W ;

RAMUZ, H .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 270 (01) :228-235

[42] In vivo pharmacology of an angiotensin AT(1) receptor antagonist with balanced affinity for angiotensin AT(2) receptors [J].

Kivlighn, SD ;

Zingaro, GJ ;

Gabel, RA ;

Broten, TP ;

Chang, RSL ;

Ondeyka, DL ;

Mantlo, NB ;

Gibson, RE ;

Greenlee, WJ ;

Siegl, PKS .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (2-3) :439-450

[43] SULFONYLUREAS AND SULFONYLCARBAMATES AS NEW NON-TETRAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - DISCOVERY OF A HIGHLY POTENT ORALLY-ACTIVE (IMIDAZOLYLBIPHENYLYL) SULFONYLUREA (HR-720) [J].

DEPREZ, P ;

GUILLAUME, J ;

BECKER, R ;

CORBIER, A ;

DIDIERLAURENT, S ;

FORTIN, M ;

FRECHET, D ;

HAMON, G ;

HECKMANN, B ;

HEITSCH, H ;

KLEEMANN, HW ;

VEVERT, JP ;

VINCENT, JC ;

WAGNER, A ;

ZHANG, JD .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (13) :2357-2377

[44] GR127935 - A POTENT ORALLY-ACTIVE 5-HT(1D) RECEPTOR ANTAGONIST [J].

SKINGLE, M ;

SCOPES, DIC ;

FENIUK, W ;

CONNOR, HE ;

CARTER, MC ;

CLITHEROW, JW ;

TYERS, MB .

BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 :P9-P9

[45] CI-966 - A POTENT, ORALLY-ACTIVE INHIBITOR OF GABA UPTAKE WITH ANTICONVULSANT ACTIVITY [J].

PAVIA, MR ;

TAYLOR, CP ;

LOBBESTAEL, SJ ;

MAYHUGH, DR ;

NUGIEL, D ;

GREGOR, VE .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 199 :117-MEDI

[46] POTENT, ORALLY ACTIVE IMIDAZO[4,5-B]PYRIDINE ANGIOTENSIN-II RECEPTOR ANTAGONISTS [J].

MANTLO, NB ;

CHAKRAVARTY, PK ;

ONDEYKA, D ;

CHEN, A ;

CAMARA, VJ ;

CHANG, RSL ;

LOTTI, VJ ;

SIEGL, PKS ;

PATCHETT, AA ;

GREENLEE, WJ .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 201 :71-MEDI

[47] MK 287 - A POTENT, SPECIFIC, AND ORALLY-ACTIVE RECEPTOR ANTAGONIST OF PLATELET-ACTIVATING-FACTOR [J].

HWANG, SB ;

LAM, MH ;

SZALKOWSKI, DM ;

MACINTYRE, DE ;

BACH, TJ ;

LUELL, S ;

MEUER, R ;

SAHOO, SP ;

ALBERTS, AW ;

CHABALA, JC .

JOURNAL OF LIPID MEDIATORS, 1993, 7 (02) :115-134

[48] METIAMIDE - AN ORALLY-ACTIVE HISTAMINE H-2-RECEPTOR ANTAGONIST [J].

BLACK, JW ;

DUNCAN, WAM ;

EMMETT, JC ;

GANELLIN, CR ;

HESSELBO, T ;

PARSONS, ME ;

WYLLIE, JH .

AGENTS AND ACTIONS, 1994, 43 (3-4) :91-96

[49] THE DISCOVERY OF L-749,329, A HIGHLY POTENT, ORALLY-ACTIVE ANTAGONIST OF ENDOTHELIN RECEPTORS [J].

WALSH, TF ;

FITCH, KJ ;

CHAKRAVARTY, PK ;

WILLIAMS, DL ;

MURPHY, KA ;

NOLAN, NA ;

OBRIEN, JA ;

LIS, EV ;

PETTIBONE, DJ ;

KIVLIGHN, SD ;

GABEL, RA ;

ZINGARO, GJ ;

KRAUSE, SM ;

SIEGL, PKS ;

CLINESCHMIDT, BV ;

GREENLEE, WJ .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 :145-MEDI

[50] ARYL AMIDINES - A NEW CLASS OF POTENT ORALLY-ACTIVE LEUKOTRIENE-B4 ANTAGONIST [J].

MAIN, AJ ;

BARSKY, LI ;

MORRISSEY, M ;

CADILLA, R ;

BOEHM, C ;

ZHANG, YC ;

SUH, HS ;

BOXER, JB ;

POWERS, DB ;

FUJIMOTO, RA ;

DOTI, RA ;

HEALY, CT ;

SELIGMANN, BE ;

UZIELFUSI, S ;

JARVIS, MF ;

SILLS, MA ;

JACKSON, RH ;

LIPSON, KE ;

CHIN, MH ;

PELLAS, TC ;

PASTOR, G ;

FRYER, LR ;

RAYCHAUDHURI, AA ;

KOTYUK, BL .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 :3-MEDI

← 1 2 3 4 5 →